129 related articles for article (PubMed ID: 31466483)
1. Profile of MeltPro® HPV test for human papillomavirus genotyping and cervical precancer screening.
Liao Y; Li Q
Expert Rev Mol Diagn; 2019 Oct; 19(10):857-862. PubMed ID: 31466483
[No Abstract] [Full Text] [Related]
2. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for improving the cervical cancer screening strategy in China.
Xu H; Lin A; Shao X; Shi W; Zhang Y; Yan W
Oncotarget; 2016 Dec; 7(50):83775-83783. PubMed ID: 27626178
[TBL] [Abstract][Full Text] [Related]
3. HPV genotyping linear assay test comparison in cervical cancer patients: implications for HPV prevalence and molecular epidemiology in a limited-resource area in Bandung, Indonesia.
Panigoro R; Susanto H; Novel SS; Hartini S; Sahiratmadja E
Asian Pac J Cancer Prev; 2013; 14(10):5843-7. PubMed ID: 24289587
[TBL] [Abstract][Full Text] [Related]
4. Universal human papillomavirus genotyping by the digene HPV Genotyping RH and LQ Tests.
Geraets DT; Lenselink CH; Bekkers RL; van Doorn LJ; Quint WG; Melchers WJ
J Clin Virol; 2011 Apr; 50(4):276-80. PubMed ID: 21296612
[TBL] [Abstract][Full Text] [Related]
5. Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.
Akbari A; Vanden Broeck D; Benoy I; Padalko E; Bogers J; Arbyn M
Virol J; 2018 Oct; 15(1):166. PubMed ID: 30373616
[TBL] [Abstract][Full Text] [Related]
6. A Head-to-Head Analytical Comparison of Cobas 4800 HPV, PapilloCheck HPV Screening, and LMNX Genotyping Kit HPV GP for Detection of Human Papillomavirus DNA in Cervical and Cervicovaginal Swabs.
Jaworek H; Koudelakova V; Drabek J; Vrbkova J; Zborilova B; Oborna I; Brezinova J; Marek R; Huml K; Vanek P; Hajduch M
J Mol Diagn; 2018 Nov; 20(6):849-858. PubMed ID: 30165205
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework.
Xu L; Oštrbenk A; Poljak M; Arbyn M
J Clin Virol; 2018 Jan; 98():37-42. PubMed ID: 29241150
[TBL] [Abstract][Full Text] [Related]
8. Identification of HPV genotypes causing cervical precancer using tissue-based genotyping.
Venetianer R; Clarke MA; van der Marel J; Tota J; Schiffman M; Dunn ST; Walker J; Zuna R; Quint W; Wentzensen N
Int J Cancer; 2020 May; 146(10):2836-2844. PubMed ID: 32037535
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the MeltPro
Tang Z; Xu Y; Song N; Zou D; Liao Y; Li Q; Pan C
Arch Virol; 2018 Mar; 163(3):725-730. PubMed ID: 29209810
[TBL] [Abstract][Full Text] [Related]
10. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
[TBL] [Abstract][Full Text] [Related]
11. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
Arbyn M; Snijders PJ; Meijer CJ; Berkhof J; Cuschieri K; Kocjan BJ; Poljak M
Clin Microbiol Infect; 2015 Sep; 21(9):817-26. PubMed ID: 25936581
[TBL] [Abstract][Full Text] [Related]
12. Profile of the BD HPV OnclarityTM assay.
Bottari F; Iacobone AD
Expert Rev Mol Diagn; 2019 Jul; 19(7):565-570. PubMed ID: 31155977
[No Abstract] [Full Text] [Related]
13. Evaluation of TypeSeq, a Novel High-Throughput, Low-Cost, Next-Generation Sequencing-Based Assay for Detection of 51 Human Papillomavirus Genotypes.
Wagner S; Roberson D; Boland J; Kreimer AR; Yeager M; Cullen M; Mirabello L; Dunn ST; Walker J; Zuna R; Porras C; Cortes B; Sampson J; Herrero R; Rodriguez AC; Quint W; Van Doorn LJ; ; Hildesheim A; Schiffman M; Wentzensen N
J Infect Dis; 2019 Oct; 220(10):1609-1619. PubMed ID: 31536132
[TBL] [Abstract][Full Text] [Related]
14. Polymerase Chain Reaction Human Papillomavirus (HPV) Detection and HPV Genotyping in Invasive Cervical Cancers With Prior Negative HC2 Test Results.
Tao X; Zheng B; Yin F; Zeng Z; Li Z; Griffith CC; Luo B; Ding X; Zhou X; Zhao C
Am J Clin Pathol; 2017 May; 147(5):477-483. PubMed ID: 28340235
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus typing by single tube multiplex amplification in real time (SMART): the PapillomaFinder® SMART 20 assay.
Ossel J; Litjens RJ; Reijans M; Brink AA; Ummelen M; Ramaekers FC; Hopman AH; Simons G
J Clin Virol; 2014 Dec; 61(4):540-7. PubMed ID: 25453331
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of human papillomavirus genotyping.
Choi YJ; Park JS
J Gynecol Oncol; 2016 Mar; 27(2):e21. PubMed ID: 26768784
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the performance in detection of HPV infections between the high-risk HPV genotyping real time PCR and the PCR-reverse dot blot assays.
Zhang L; Dai Y; Chen J; Hong L; Liu Y; Ke Q; Chen Y; Cai C; Liu X; Chen Z
J Med Virol; 2018 Jan; 90(1):177-183. PubMed ID: 28851089
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Associated Factors of Abnormal Cervical Cytology and HighRisk HPV DNA among Bangkok Metropolitan Women.
Tangjitgamol S; Kantathavorn N; Kittisiam T; Chaowawanit W; Phoolcharoen N; Manusirivithaya S; Khunnarong J; Srijaipracharoen S; Saeloo S; Krongthong W; Supawattanabodee B; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(7):3147-53. PubMed ID: 27509943
[TBL] [Abstract][Full Text] [Related]
19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
[TBL] [Abstract][Full Text] [Related]
20. HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
Pasquier C; Raymond S; Carcenac R; Demmou S; Ranger N; Nicot F; Izopet J
J Med Virol; 2024 May; 96(5):e29652. PubMed ID: 38727029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
